Biblio

Export 76 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is V  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
C. Vakalopoulos, “Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.”, J Alzheimers Dis, vol. 60, no. 3, pp. 859-866, 2017.
V. Valdiglesias, Maseda, A., Lorenzo-López, L., Pásaro, E., Millán-Calenti, J. C., and Laffon, B., “Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1509-1517, 2017.
N. Valech, Tort-Merino, A., Coll-Padrós, N., Olives, J., León, M., Rami, L., and Molinuevo, J. Luis, “Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.”, J Alzheimers Dis, vol. 61, no. 2, pp. 689-703, 2018.
R. Valenti, Charidimou, A., Xiong, L., Boulouis, G., Fotiadis, P., Ayres, A., Riley, G., Kuijf, H. J., Reijmer, Y. D., Pantoni, L., M Gurol, E., Davidsdottir, S., Greenberg, S. M., and Viswanathan, A., “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
C. Pieternell van Buuren, van der Steen, J. Theodora, Olthof-Nefkens, M., Bakker, C., Koopmans, R. Theodorus, Perry, M., and Kalf, J. Gezina, “The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
I. E. van de Vorst, Koek, H. L., Bots, M. L., and Vaartjes, I., “Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning.”, J Alzheimers Dis, vol. 53, no. 1, pp. 117-25, 2016.
E. van den Berg, Geerlings, M. I., Biessels, G. Jan, Nederkoorn, P. J., and Kloppenborg, R. P., “White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.”, J Alzheimers Dis, vol. 63, no. 2, pp. 515-527, 2018.
E. van den Berg, Nilsson, J., Kersten, I., Brinkmalm, G., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Jäkel, L., Gobom, J., Portelius, E., Zetterberg, H., Brinkmalm, A., Blennow, K., H Kuiperij, B., and Verbeek, M. M., “Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 467-475, 2023.
W. M. van der Flier and Scheltens, P., “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
F. C. T. van der Heide, Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Schram, M. T., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Wesselius, A., Savelberg, H. H. C. M., Schaper, N. C., Webers, C. A. B., and Stehouwer, C. D. A., “Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.
M. D. van der Hoek, Nieuwenhuizen, A., Keijer, J., and J Ashford, W., “The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 3, pp. 1045-1054, 2019.
A. T. van der Ven, Pape, J. C., Hermann, D., Schloesser, R., Genius, J., Fischer, N., Mößner, R., Scherbaum, N., Wiltfang, J., Rujescu, D., and Benninghoff, J., “Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 2, pp. 531-540, 2017.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
S. van Duijn, Bulk, M., van Duinen, S. G., Nabuurs, R. J. A., van Buchem, M. A., van der Weerd, L., and Natté, R., “Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1533-1545, 2017.
E. van Duinkerken, Farme, J., Landeira-Fernandez, J., Dourado, M. C., Laks, J., and Mograbi, D. C., “Medical and Research Consent Decision-Making Capacity in Patients with Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 3, pp. 917-930, 2018.
T. Van Langenhove, Piguet, O., Burrell, J. R., Leyton, C., Foxe, D., Abela, M., Bartley, L., Kim, W. S., Jary, E., Huang, Y., Dobson-Stone, C., Kwok, J. B., Halliday, G. M., and Hodges, J. R., “Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 1, pp. 163-170, 2017.
T. Van Langenhove, Leyton, C. E., Piguet, O., and Hodges, J. R., “Comparing Longitudinal Behavior Changes in the Primary Progressive Aphasias.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1033-42, 2016.
T. van Middelaar, van Dalen, J. W., van Gool, W. A., van den Born, B. - J. H., van Vught, L. A., van Charante, E. P. Moll, and Richard, E., “Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.”, J Alzheimers Dis, vol. 62, no. 2, pp. 727-735, 2018.
L. D. Van Mierlo, Wouters, H., Sikkes, S. A. M., van der Flier, W. M., Prins, N. D., Bremer, J. A. E., Koene, T., and Van Hout, H. P. J., “Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests.”, J Alzheimers Dis, vol. 56, no. 1, pp. 249-259, 2017.
S. van Rooden, van den Berg-Huysmans, A. A., Croll, P. H., Labadie, G., Hayes, J. M., Viviano, R., van der Grond, J., Rombouts, S. A. R. B., and Damoiseaux, J. S., “Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1283-1294, 2018.
J. van Santen, Dröes, R. - M., Holstege, M., Henkemans, O. Blanson, van Rijn, A., de Vries, R., van Straten, A., and Meiland, F., “Effects of Exergaming in People with Dementia: Results of a Systematic Literature Review.”, J Alzheimers Dis, vol. 63, no. 2, pp. 741-760, 2018.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W., “Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.”, J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
I. W. M. van Uden, van der Holst, H. M., Tuladhar, A. M., van Norden, A. G. W., de Laat, K. F., Rutten-Jacobs, L. C. A., Norris, D. G., Claassen, J. A. H. R., van Dijk, E. J., Kessels, R. P. C., and de Leeuw, F. - E., “White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 863-73, 2016.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., “NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.

Pages